Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting

Abstract:
Diasome Pharmaceuticals, a clinical stage diabetes therapeutics company, announced today that four abstracts were accepted for publication at the 68th Annual Meeting of the American Diabetes Association, being held June 6 through June 10 at the Moscone Convention Center in San Francisco, Ca.

Diasome Pharmaceuticals to Present at the 68th Annual American Diabetes Association Meeting

CONSHOHOCKEN, PA | Posted on May 20th, 2008

All of the abstracts highlight HDV-Insulin, the Company's proprietary oral and injectable insulin products. The following will be presented as posters from Saturday, June 7 through Monday, June 9 in Hall D:

* A 2-Week Randomized Active Comparator Study of Two HDV-Insulin Routes (SC and Oral) and SC Human Insulin in Patients with Type 1 Diabetes Mellitus. Sherwyn Schwartz, MD, Blair Geho, MD, PhD, Len Rosenberg, PhD, RPh, John Lau. Diabetes and Glandular Research Center, San Antonio, TX, and Diasome Pharmaceuticals, Conshohocken, PA.
* Single-Blind, Placebo-Controlled, Dose-Ranging Trial of Oral HDV-Insulin in Patients with Type 2 Diabetes Mellitus. Sherwyn Schwartz, MD, Blair Geho, MD, PhD, Len Rosenberg, PhD, RPh, John Lau. Diabetes and Glandular Research Center, San Antonio, TX, and Diasome Pharmaceuticals, Conshohocken, PA.
* Hepatic-Directed Vesicle Insulin: Evaluation of a Novel Oral and Subcutaneous Insulin Delivery System in Animal Models of Diabetes. Blair Geho, MD, PhD, John Lau, Len Rosenberg, PhD, RPh, Diasome Pharmaceuticals, Conshohocken, PA.

In addition, presenters will be on hand Saturday, June 7, from 11:30 a.m. to 1:30 p.m., and on Monday, June 9, from noon to 2 p.m. for questions and discussions with attendees.

Diasome is developing Oral HDV-Insulin, a nanotechnology-based cell targeting system for the improved treatment of diabetes mellitus. Diasome's therapies have been tested in more than 100 subjects to date. The Company is preparing to conduct longer term clinical trials in 2008 after having held an end of Phase II meeting with the FDA in 2007.

####

About Diasome Pharmaceuticals, Inc.
Diasome Pharmaceuticals, Inc. is a venture-backed biopharmaceutical company focused on novel insulin-based therapies for the improved treatment of diabetes. The Company was formed in 2004 and has completed multiple Phase II human studies of HDV-Insulin, its proprietary insulin targeting system. Diasome uses a unique, nano-technology based cell targeting system to preferentially deliver insulin to the hepatocytes in the liver. This technology has led to the development of Oral HDV-Insulin, an advanced oral delivery system for insulin. For more information, please visit Diasome’s website at www.Diasome.com.

About the American Diabetes Association

The American Diabetes Association (ADA) is the nation’s premier voluntary health organization supporting diabetes research, information and advocacy. Founded in 1940, the Association's mission is to prevent and cure diabetes and to improve the lives of all people affected by diabetes. The Association’s commitment to research is reflected through its scientific meetings; education and provider recognition programs; and its Research Foundation and Nationwide Research Program, which fund breakthrough studies looking into the cure, prevention, and treatment of diabetes and its complications. www.Diabetes.org

For more information, please click here

Contacts:
Gregory FCA
Theresa Murray
610-642-8253 x164

Copyright © Business Wire 2008

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

East China University of Science and Technology Purchases Nanonex Advanced Nanoimprint Tool NX-B200 July 30th, 2014

Watching Schrödinger's cat die (or come to life): Steering quantum evolution & using probes to conduct continuous error correction in quantum computers July 30th, 2014

From Narrow to Broad July 30th, 2014

FLAG-ERA and TNT2014 join efforts: Graphene Networking at its higher level in Barcelona: Encourage the participation in a joint transnational call July 30th, 2014

Nanomedicine

New imaging agent provides better picture of the gut July 30th, 2014

Zenosense, Inc. July 29th, 2014

Optimum inertial design for self-propulsion: A new study investigates the effects of small but finite inertia on the propulsion of micro and nano-scale swimming machines July 29th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

Announcements

University of Manchester selects Anasys AFM-IR for coatings and corrosion research July 30th, 2014

Nature inspires a greener way to make colorful plastics July 30th, 2014

Analytical solutions from Malvern Instruments support University of Wisconsin-Milwaukee researchers in understanding environmental effects of nanomaterials July 30th, 2014

FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014

Events/Classes

FLAG-ERA and TNT2014 join efforts: Graphene Networking at its higher level in Barcelona: Encourage the participation in a joint transnational call July 30th, 2014

FEI Unveils New Solutions for Faster Time-to-Analysis in Metals Research July 30th, 2014

WITec to host the 11th Confocal Raman Imaging Symposium from September 29th - October 1st in Ulm, Germany July 28th, 2014

FEI adds Phase Plate Technology and Titan Halo TEM to its Structural Biology Product Portfolio: New solutions provide the high-quality imaging and contrast necessary to analyze the 3D structure of molecules and molecular complexes July 28th, 2014

NanoNews-Digest
The latest news from around the world, FREE



  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE